Université de Paris, MERIT, IRD, F-75006 Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.
ACS Infect Dis. 2020 Jul 10;6(7):1532-1547. doi: 10.1021/acsinfecdis.9b00430. Epub 2020 Apr 20.
Three novel tracers designed as fluorescent surrogates of artemisinin-derived antimalarial drugs (i.e., dihydroartemisinin, artemether, arteether, and artemisone) were synthesized from dihydroartemisinin. One of these tracers, corresponding to a dihydroartemisinin/artemether/arteether mimic, showed a combination of excellent physicochemical and biological properties such as hydrolytic stability, high inhibitory potency against blood-stage parasites, similar ring-stage survival assay values than the clinical antimalarials, high cytopermeability and specific labeling of live cells, alkylation of heme, as well as specific covalent labeling of drug-sensitive and drug-resistant proteomes at physiological concentrations, consistent with a multitarget action of the drugs. Our study demonstrates that probes containing the complete structural core of clinical artemisinin derivatives can be stable in biochemical and cellular settings, and recapitulate the complex mechanisms of these frontline, yet threatened, antimalarial drugs.
三种新型示踪剂被设计为青蒿素类抗疟药物(即双氢青蒿素、青蒿琥酯、蒿甲醚和青蒿素)的荧光类似物,由双氢青蒿素合成。这些示踪剂中的一种,对应于双氢青蒿素/青蒿琥酯/蒿甲醚模拟物,表现出优异的理化和生物学特性的结合,如水解稳定性、对血期寄生虫的高抑制效力、与临床抗疟药物相似的环期存活测定值、高细胞通透性和对活细胞的特异性标记、血红素的烷基化以及在生理浓度下对药物敏感和耐药蛋白质组的特异性共价标记,与这些药物的多靶点作用一致。我们的研究表明,含有临床青蒿素衍生物完整结构核心的探针在生化和细胞环境中可以稳定,并再现这些一线但受到威胁的抗疟药物的复杂机制。